4//SEC Filing
Hallam Thomas 4
Accession 0001493152-22-023511
CIK 0001357459other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 9:06 PM ET
Size
10.0 KB
Accession
0001493152-22-023511
Insider Transaction Report
Form 4
Hallam Thomas
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock, par value $0.01
2022-08-16$0.25/sh+40,000$10,000→ 57,592 total - Purchase
Series 1 Common Stock Purchase Warrant
2022-08-16+40,000→ 40,000 totalExercise: $0.25Exp: 2023-08-16→ Common Stock (40,000 underlying) - Purchase
Series 2 Common Stock Purchase Warrant
2022-08-16+40,000→ 40,000 totalExercise: $0.25Exp: 2027-08-16→ Common Stock (40,000 underlying)
Footnotes (3)
- [F1]Represents common shares underlying 40,000 Units of Issuer purchased by Reporting Person ("Units") in Underwritten Offering with each Unit containing (i) one share of common stock, (ii) one Series 1 Warrant and (iii) One Series 2 Warrant at a price per Unit of $0.25.
- [F2]Represents Series 1 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 1 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4.
- [F3]Represents Series 2 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 2 Warrants are exercisable upon receipt of stockholder approval per Nasdaq rules, which has not been obtained as of the date of this Form 4.
Documents
Issuer
PALISADE BIO, INC.
CIK 0001357459
Entity typeother
Related Parties
1- filerCIK 0001850921
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 9:06 PM ET
- Size
- 10.0 KB